Finzati - Logo
CRIS logo

Curis, Inc.

CRIS • Biotechnology
$1.35
▼ -0.02 (-1.46%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$261.41M
Growth
-20.7%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.3Weak liquidity · 0.49Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 12, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.35
Change-1.46%
Shares Out193.63M
Market Cap$261.41M
Enterprise Value$247.63M
52W Range0.18 - 2.48
Beta3.08
P/E-12.35
P/S37.01
P/B20.57
P/FCF-9.03
EV/Sales35.06

Investment DNA

How strong this company looks for long-term investors

24
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
38/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0.3Weak liquidity · 0.49Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

CRIS
Analyst sentiment
Based on 18 analyst votes · 2026-09-05
94/100
Bullish
Bullish
16
Hold
2
Bearish
0

Company Overview

IPO: 8/1/2000
Industry: Biotechnology
P/B i: 20.57
Debt / Equity i: 0.30
Operating Margin: -348.43%
Net Margin: -80.29%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 0.30
Current Ratio: 0.49
Quick Ratio: 0.49
Status: Moderate

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

KAITIN KENNETH I
Transaction: 03/31/2026
BUY
Change
+10,000
Price
$0.55
Filing
04/01/2026
Type
BUY
Rubin Marc
Transaction: 03/20/2026
SELL
Change
-20
Price
Not reported
Filing
03/23/2026
Type
SELL
Rubin Marc
Transaction: 03/20/2026
BUY
Change
+26,667
Price
Not reported
Filing
03/23/2026
Type
BUY